Aug 11, 2018

Rep. Collins suspends re-election campaign following insider trading charges

Rep. Chris Collins (R-NY) walks out of a New York court house after being charged with insider trading. Photo: Spencer Platt/Getty Images

Rep. Chris Collins (R-NY) has announced he is suspending his re-election campaign after being charged with insider trading stemming from the sale of shares in a company called Innate Immunotherapeutics.

Collins explains the suspension is in the "best interests of his constituents" and will fill out the remaining months of his term. Since being charged, he has shown confidence that he will be cleared and kept that belief in today's statement saying he will continue to fight the charges and looks forward to being "cleared of any wrongdoing."

Go deeper

Snapchat will no longer promote Trump's account in Discover

Photo: Chip Somodevilla/Getty Images

Snapchat will no longer promote President Trump's account on its "Discover" page of curated content, a spokesperson tells Axios, after Trump tweeted comments that some suggested glorified violence amid racial justice protests.

Why it matters: Snapchat is taking action on the president's account for comments he made elsewhere. That's going farther than other big tech firms and signals a commitment to aligning content served to users with core values, rather than making moderation decisions based narrowly on each post made on its own platform.

Updated 1 hour ago - Politics & Policy

Esper catches White House off guard with opposition to military use, photo op

Defense Secretary Mark Esper said at a press briefing Wednesday that he does not support invoking the Insurrection Act, an 1807 law that permits the president to use active-duty troops on U.S. soil, in order to quell protests against racial injustice.

Why it matters: President Trump threatened this week to deploy military forces if state and local governments aren't able to squash violent protests. Axios reported on Wednesday that Trump is backing off the idea for now, but that he hasn't ruled it out.

Chinese coronavirus test maker agreed to build a Xinjiang gene bank

Illustration: Annelise Capossela/Axios

A leading Chinese gene sequencing and biomedical firm that said it would build a gene bank in Xinjiang is supplying coronavirus tests around the world.

Why it matters: U.S. officials are worried that widespread coronavirus testing may provide an opportunity for state-connected companies to compile massive DNA databases for research as well as genetics-based surveillance.